Edwards LifesciencesvsEli Lilly and Company

EW and LLY stock compared: price, dividend, valuation and results, from SEC filings.

EW

Edwards Lifesciences Corporation

$107.11

Value $62.2B

-0.04%
EW's page

LLY

Eli Lilly and Company

$1,431.67

Value $1.35T

-0.82%
LLY's page

Edwards Lifesciences (EW) has a market value of $62.2B and Eli Lilly and Company (LLY) $1.35T. Over the last year, with dividends, EW moved +24.1% and LLY +40.5%. The P/E is 60.9 for EW and 49.0 for LLY. Dividend yield: EW none, LLY 0.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EW$62.2B

    LLY$1.35T

    LLY is 22 times EW

  • Revenue, 12 months

    EW$6.7B

    LLY$86.5B

    LLY is 13 times EW

  • Net income, 12 months

    EW$1.0B

    LLY$27.6B

    LLY is 27 times EW

  • Operating margin

    EW21.6%

    LLY–

  • ROIC

    EW9.0%

    LLY35.5%

    26.5 points apart

  • P/E

    EW60.9

    LLY49.0

    EW is 1.2 times LLY

  • Dividend yield

    EW0.0%

    LLY0.4%

    0.4 points apart

  • 5-year return

    EW-8.2%

    LLY+478.4%

    486.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EW-8.2%

LLY+478.4%

20040060020222023202420252026
Returns by period
PeriodEWWith dividendsLLYWith dividends
1 year since November 14, 2025+24.1%Price +24.1%+40.5%Price +39.6%
3 years since November 16, 2023+58.8%+16.7% a yearPrice +58.8%+148.1%+35.4% a yearPrice +143.2%
5 years since November 15, 2021-8.2%-1.7% a yearPrice -8.2%+478.4%+42.1% a yearPrice +454.0%
10 years since November 16, 2016+260.5%+13.7% a yearPrice +260.5%+2,064.5%+36.0% a yearPrice +1,760.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EWEdwards LifesciencesLLYEli Lilly and Company

Valuation

EWLLY
Valuation
Price$107.11$1,431.67
Market value$62.2B$1.35T
Enterprise value (EV)$58.2B$1.40T
P/E60.949.0
P/E, 5-year median33.249.9
P/B5.733.5
EV/EBIT40.440.1
Free cash flow yield2.3%1.5%

Results and growth

EWLLY
Results and growth
Revenue, 12 months$6.7B$86.5B
Net income, 12 months$1.0B$27.6B
Free cash flow, 12 months$1.4B$19.7B
Earnings per share, 12 months$1.77$30.81
Revenue growth, year on year11.6%44.7%
Revenue growth a year, past+6.7%over 5 years+21.6%over 5 years
EPS growth a year, past+7.1%over 5 years+27.6%over 5 years

Margins and returns on capital

EWLLY
Margins and returns on capital
Gross margin78.0%83.6%
Operating margin21.6%–
Net margin15.3%31.9%
ROIC9.0%35.5%
ROE9.8%88.6%

Balance sheet

EWLLY
Balance sheet
Cash$4.6B$4.9B
Total debt$705M$49.5B
Net debt / EBITDA-2.51.2
Interest cover70.6×38.9×

Dividends and buybacks

EWLLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield1.4%0.3%
Shareholder yield1.4%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EW or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Edwards Lifesciences or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.35T) is about 21.7 times Edwards Lifesciences ($62.2B), at today's prices.

How did EW and LLY stock do over the last 10 years?

Since November 16, 2016, EW's price moved +260.5% and LLY's +1,760.8%. With dividends: EW +260.5% (+13.7% a year), LLY +2,064.5% (+36.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, EW or LLY?

The dividend yield at today's price is none for Edwards Lifesciences and 0.44% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of EW and LLY?

At today's price, the P/E is 60.9 for EW and 49.0 for LLY. The median of the last five years was 33.2 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, Edwards Lifesciences or Eli Lilly and Company?

Over the last twelve months, the net margin was 15.3% for Edwards Lifesciences and 31.9% for Eli Lilly and Company, and the operating margin 21.6% and –. Revenue was $6.7B and $86.5B.

Which is the better investment, Edwards Lifesciences or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.